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Abstract 
EDTA is widely used as an inhibitor of bacterial growth, affecting the uptake and control of metal 
ions by microorganisms.  We describe the synthesis and characterisation of two symmetrical bis-
amide derivatives of EDTA, featuring glycyl or pyridyl substituents: AmGly2 and AmPy2.  Metal 
ion affinities (log K) have been evaluated for a range of metals (Mg2+, Ca2+, Fe3+, Mn2+, Zn2+), 
revealing less avid binding compared to EDTA.  The solid state structures of AmGly2 and of its 
Mg2+ complex have been determined crystallographically. The latter shows an unusual 7-
coordinate, capped octahedral Mg2+ centre. The antibacterial activities of the two ligands and of 
EDTA have been evaluated against a range of health-relevant bacterial species, three Gram 
negative (Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae) and a Gram 
positive (Staphylococcus aureus).  The AmPy2 ligand is the only one that displays a significant 
inhibitory effect against K. pneumoniae, but is less effective against the other organisms.  AmGly2 
exhibits a more powerful inhibitory effect against E. coli at lower concentrations than EDTA (< 3 
mM) or AmPy2, but loses its efficacy at higher concentrations.  The growth inhibition of EDTA 
and AmGly2 on mutant E. coli strains with defects in outer-membrane lipopolysaccharide (LPS) 
structures has been assessed in order to provide insight into the unexpected behaviour.  Taken 
together, the results contradict the assumption of a simple link between metal ion affinity and 
antimicrobial efficacy. 
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1.  Introduction 
 
A number of strategies can be employed to kill bacteria or restrict their growth, such as the use of 
oxidising solutions like bleach, elemental copper on surfaces, irradiation of materials with γ-rays 
and, more recently, exposure to nanoparticulate matter.[1–3] In addition to these ‘inorganic’ 
approaches, a battery of organic compounds can be applied, including disinfectants to disrupt 
bacterial cell envelopes, and antibiotics that target fundamental bacterial processes, often in a highly 
specific manner (e.g. blocking cell wall synthesis).  Depriving bacteria of nutrients essential for 
growth, especially metal ions, can also prove effective[4–7] since metal ions are critical for the proper 
function of many enzymes and also play a role in resistance to oxidative stress.[8,9]  
 
Metal ion starvation can be achieved by employing chelating ligands.  Because of its ability to form 
stable complexes with a variety of metal ions, EDTA (Figure 1) is commonly incorporated in 
preservative formulations in many consumer products as diverse as mayonnaise and face 
cream.[10,11] 
 
As part of a program to develop new chelating ligand systems that could be deployed in similar 
fashion to EDTA, we surveyed the literature and found that, although a number of chelators have 
been investigated as potential antibacterials, their effect on biological systems was rarely 
rationalised in terms of their metal ion binding affinities.[12]  Exceptions include two studies that 
treated the qualitative chelating ability of an aminocarboxylate ligand as a predictor of antibacterial 
activity, albeit without reference to specific metal ions. [13,14] 
 
More recently, work on Fe3+–sequestering agents demonstrated that ligands with greater p(Fe3+) 
display lower minimum inhibitory concentration (MIC) values when a range of bacterial species 
were exposed to them {note that p(Mn+) = –log10[Mn+]free, where [Mn+] is the concentration of “free” 
metal ion; high values are indicative of strong binding}.[15,16]  It might indeed be intuitive to expect 
that an increased metal ion affinity of a ligand would correlate with an increased level of metal ion 
depletion in a given bacterial growth environment, and consequently increase the likelihood of a 
detrimental effect on bacterial growth.  In this study, we communicate our findings on two 
symmetrical bis-amide derivatives of EDTA, namely AmGly2 and AmPy2 (Figure 1), which 
contradict this attractive yet apparently overly simplistic interpretation, by showing that metal ion 
binding characteristics alone are not necessarily good predictors of the antibacterial effect of a given 
chelating ligand. 
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Figure 1. The structures of the two ligands considered in this work, AmGly2 and AmPy2, which are 
bis-amide derivatives of EDTA, whose structure is also shown for reference. 
 
2.  Results and discussion 
 
2.1 Synthetic strategies 
 
Although structurally similar to one another, AmGly2 and AmPy2 were best prepared by different 
routes.  We were able to access AmGly2 in gram-scale quantities via the nucleophilic ring opening 
of the symmetrical bis-anhydride of EDTA with glycine (Scheme 1) in a single step, without the 
need for protecting groups and in reasonable yields (ca. 40%).  Occasionally, crystals of AmGly2 
suitable for analysis by single crystal X-ray diffraction were isolable from synthetic runs (see 
Section 2.3 below). 
	  
Scheme 1. Synthesis of AmGly2 from the bis-anhydride of EDTA 
 
This procedure can be considered a complement to that reported by Heathman,[17] in which the bis-
anhydride of EDTA is ring-opened by the ethyl ester of glycine, followed by basic hydrolysis to 
afford AmGly2.  Higher overall yields of the product were reported compared to the one-pot 
approach described here, although the overall process is lengthier. 
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The same anhydride-based approach[18] was trialled for the synthesis of AmPy2, but the strategy led 
to the formation of a crude mixture that was not amenable to conventional purification methods.  A 
different approach was therefore adopted (Scheme 2), based on successive N-alkylation and 
protected intermediates that could easily be purified by column chromatography, similar to those 
pervasively used in the synthesis of chelating agents intended for lanthanide complexation.[19]  
 
	  
Scheme 2. Synthesis of AmPy2 using the dibenzyl protection route 
	  
Preparation of intermediates 1–3 was straightforward using previously reported procedures.  The 
structure of 1 in the solid state was determined by X-ray diffraction during the course of the work.  
Details are provided in the Supporting Information (Table S1).  Alkylation of 2 with 3 gave 
amidoester 4, which was purified via reverse phase column chromatography on a preparative scale 
prior to t-butyl ester deprotection in the presence of anisole as a cation scavenger, to afford AmPy2 
as its trifluoroacetate salt.  The trifluoroacetate salt of AmPy2 was then passed down a column of 
DOWEX 1X8 anion exchange resin to remove any residual trifluoroacetate ion that could interfere 
with subsequent biological and pH-potentiometric studies of AmPy2.  The identities of AmGly2 and 
AmPy2 were confirmed by 1H and 13C NMR spectroscopy and electrospray mass spectrometry 
techniques, and sample purity evaluated by analytical HPLC.  Combustion analysis gave 
satisfactory %CHN analytical data for AmGly2, though the hygroscopic nature of AmPy2 led to 
results a little out of range. 
 
 
2.2  Potentiometric measurements: protonation constants and metal affinities 
 
Solutions for study were prepared containing 1 mM of the analyte ligand at an ionic strength of 
0.15 M maintained using KCl.  Four protonation constants were determined for both AmGly2 and 
AmPy2 with the first two protonations of each occurring at lower values than those of EDTA (Table 
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1).  For all three ligands, the first protonation will take place on a tertiary amine group on the 
central ethylenediamine.  The first protonation values are lower for AmGly2 and AmPy2 fragment 
due to the weakly electron-withdrawing effect that the amide groups exert on the neighbouring 
amines.  Assignment of subsequent protonation events to either pyridines or carboxylates in AmPy2 
on the basis of pH-potentiometry alone is not realistic due to the small differences in the protonation 
constants between each functional group.[62] 
 
The protonation data were subsequently used to calculate metal ion–ligand association constants, as 
described in the Supporting Information.  We selected five di/trivalent metal ions for study, being 
those commonly found in significant concentrations in biological systems (Ca2+, Mg2+, Fe3+, Mn2+ 
and Zn2+).[8]  The resulting values are tabulated in Table 2. 
 
What is immediately apparent from the data is the inferior binding of metal ions displayed by 
AmGly2 and AmPy2 in their fully deprotonated (L) forms compared to EDTA.  Since the metal 
ions studied (Ca2+, Mg2+, Fe3+, Mn2+ and Zn2+) are all relatively hard, the loss of two charged, non-
pendent carboxylate donor groups going from EDTA to AmGly2 and AmPy2 may in part be 
responsible for the reduction in chelate stability.  The order of complex stability, namely 
Fe3+ > Zn2+ > Mn2+ > Ca2+ > Mg2+, is preserved in the case of the fully deprotonated forms of each 
ligand, meaning that changing the donor set from a tetracarboxylate to a biscarboxylate–bisamide 
configuration does not alter the selectivity of AmGly2 and AmPy2 for different metals compared to 
EDTA at high pH. 
 
The more Lewis acidic metal ions (Fe3+, Mn2+ and Zn2+) studied can either form hydroxo- 
complexes with AmGly2 and AmPy2, or switch amide coordination mode from O– to N– 
coordination following deprotonation of the amide nitrogen atoms, as shown by the existence of 
MLH–n (n = 1, 2, 3) species in solution.[63]  Speciation diagrams for AmGly2 are shown in Figure 2; 
corresponding diagrams for AmPy2 are provided in the Supporting Information (Figure S4). 
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Table 1. Protonation constants at 25°C, I = 0.15 M KCl, for AmGly2 and AmPy2, with values for 
EDTA included for comparison. Charges are omitted for clarity. Data are the average of two 
independent experiments with the standard deviation in the last decimal place shown in 
parentheses. Previously published values for AmGly2 are included for comparison with the 
experimental data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Equilibrium[a] 
log K(AmGly2) 
log K(AmPy2) log K(EDTA)[b] 
exp. lit.[b] 
L + H D HL 7.22(2) 7.34 7.34(2) 10.17 
HL + H D H2L 4.17(2) 4.35 5.10(2) 6.11 
H2L + H D H3L 3.54(3) 3.63 4.22(2) 2.68 
H3L + H D H4L 3.38(3) 2.96 2.96(2) 2.0 
H4L + H D H5L - 1.81 - 1.5 
Log ß[d] 18.30(3) 20.09 19.62(3) 22.46 
[a] Charges omitted. 
[b] Values averaged from data reported by Martell[63] and Heathman[17] at T = 25°C. 
[c] Data from Martell and Smith[64] at T = 25°C and I = 0.1M. 
[d] log𝛽 = log𝐾. 
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Table 2. Stepwise formation constants at 25°C, I = 0.15 M KCl for metal ion complexes of AmGly2 
and AmPy2. Values are the average of two independent experiments. The values in parentheses are 
the standard deviation in the last significant figure. Published values for EDTA are shown for 
comparison. 
Equilibrium[a] Ca2+ Mg2+ Fe3+ Mn2+ Zn2+ 
AmGly2[b] 
ML + H  D MHL 3.34(5) 4.78(6) - 3.53(2) 3.58(2) 
M + L D ML 6.95(1) 5..05(2) 11.76(3) 9.22(1) 10.36(2) 
ML D MLH-1 + H -10.84(3) -10.68(4) -3.69(2) -10.32(2) -9.07(2) 
MLH-1  D MLH-2 +H - - --10.11(2) - -10.88(3) 
MLH-2 D MLH-3 + H - - 
-10.30(7) - - 
AmPy2[c] 
MHL + H  D MH2L    3.81(2) 3.75(4) 
ML + H  D MHL - - 3.19(3) 4.74(4) 4.86(6) 
M + L D ML 6.56(3) 3.38(9) 12.76(2) 8.64(4) 10.4(1) 
ML D MLH-1 + H - -10.5(1) -4.52(5) -1.26(5) -8.10(5) 
MLH-1  D MLH-2 +2H - - -9.55(8) -10.34(6) -10.1(2) 
EDTA[d] 
M L + H  D MHL - - - 3.10 3.00 
M + L D ML 10.61 8.83 25.0 13.81 16.44 
[a] Charges omitted. 
[b] Accompanying speciation diagrams for AmGly2 are given in Figure 2. 
[c] Speciation diagrams for AmPy2 are given in Supporting Information, Figure S4. 
[d] Data from Martell and Smith[64] at T = 25ºC and I = 0.1M KCl. 
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Figure 2. Distribution plots of the systems L:M (L = AmGly2; M = H+, Ca2+, Mg2+, Fe3+, Mn2+, 
and Zn2+) in 1:1 molar ratio, [L] = [M] = 1 × 10–3 M (charges are omitted for clarity).   
 
  
- 9 - 
From the studies performed, it seems unlikely that AmGly2 and AmPy2 form multinuclear species 
in which the donor groups appended to the amide linkage (i.e. –CH2CO2H for AmGly2 and               
–CH2C5H4N for AmPy2) participate in binding to the metal ions studied, since the fitting of the 
potentiometric data does not improve significantly when these systems are accounted for in the 
fitting models used.  These groups may instead be used to interact with other cations present at 
higher concentrations than the metal ions investigated, which may in turn facilitate the formation of 
polymeric structures in the solid state, as discussed in Section 2.3 below. 
 
A more useful expression of the metal ion affinity for these ligands can be found in quantities such 
as p(Mn+) = –log10[Mn+]free [67], a measure of the free metal ion concentration in solution (analogous 
to pH) that can be calculated as described in the Supporting Information.[68]  The measured factors 
in all of the relevant solution equilibria determined for EDTA, AmGly2 and AmPy2 at a given pH 
and the pM values thus calculated are shown in Table 3. 
 
Table 3. p[Mn+] values at pH 7.4 at 25oC, I = 0.15M KCl for AmGly2 and AmPy2. [L] = 10 µmol 
dm–3 and [Mn+] = 1 µmol dm–3. 
Species AmGly2 AmPy2 EDTA 
Ca2+ 7.7 7.2 8.8 
Mg2+ 16.2 4.1 7.0 
Fe3+ 16.2 16.3 23.2 
Mn2+ 9.9 9.3 12.0 
Zn2+ 11.1 11.1 14.6 
 
Upon accounting for the multiple species in solution for each metal ion-ligand pair at pH 7.4 (a 
typical pH value for buffered liquid media such as Iso-sensitest), the trend in metal ion affinity is 
preserved with Fe3+ being the metal ion most extensively sequestered and Mg2+ the least.  
Moreover, when comparing the p(Mn+) values calculated for AmGly2 and AmPy2, only small 
differences are noted with the most notable disparity being the p(Mg2+), demonstrating the more 
extensive sequestration ability of AmGly2 for Mg2+ compared to AmPy2.  Most importantly, the 
p(Mn+) values at pH 7.4 clearly show that both AmGly2 and AmPy2 sequester all metal ions less 
extensively compared to EDTA, even when the multiple species present at pH 7.4 are taken into 
account. Both of these points will be returned to following discussion of the bacteriostatic action in 
Section 2.4. 
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2.3  Solid-state structures: AmGly2 and its Mg2+ complex  
 
Single crystals suitable for X-ray diffraction analysis were obtained by the repeated recrystallization 
of metal-free AmGly2 in water.  Slow evaporation of a solution prepared from a mixture of 
AmGly2 and Mg(NO3)2 at alkaline pH gave crystals of the magnesium complex Mg(AmGly2)NO3, 
which were also amenable to X-ray crystallography.  Crystal data are summarised in Table S1 of the 
Supporting Information. 
 
The structure of AmGly2 in the crystal reveals that the ligand is in its zwitterionic form (Figure 3).  
The carboxylate groups attached directly to the ethylenediamine unit (i.e. those containing oxygens 
O4 and O5 in the Figure) exist as their anions, and the tertiary amines (N1) in each molecule are 
protonated.  These protons on the tertiary amines participate in moderately strong intramolecular 
hydrogen bonding to the amide carbonyl oxygen atoms, d(H—O1) = 2.145Å.  In general, the 
measured bond lengths and angles do not greatly deviate from their expected ideal values. 
	  
Figure 3.  Molecular structure in the crystal of the AmGly2 ligand, present as the zwitterionic form. 
Dashed line represent hydrogen bonds with their length in Å.  Thermal ellipsoids are shown at the 
50% probability level.  For clarity, only crystallographically unique heteroatoms, or those involved 
in intramolecular hydrogen bonding interactions, are labelled. 
	  
The Mg2+ complex Mg(AmGly2)NO3 has a 1:1 stoichiometry with the central Mg2+ ion adopting an 
unusual seven-coordinate geometry in a capped octahedral configuration (Figure 4, with key bond 
lengths and angles summarised in Table 4).  The equivalent carboxylate oxygen atoms O5 are 
mutually trans to one another.  Similarly the amide oxygen atoms are trans to one another, but in 
the equatorial plane.  The ethylenediamine nitrogen atoms (N2) and a water molecule disordered 
across two sites bound to the central Mg2+ via oxygen (O6) complete the coordination sphere.  
There is one nitrate ion per magnesium ion in the crystal; charge balance is presumably maintained 
by a proton whose location is undetermined. 
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The Mg2+–to–donor bond lengths are fairly typical of other crystallographically characterised 
Mg2+–aminocarboxylate complexes.[69–71]  The amide oxygen–Mg2+ bond lengths are seen to be 
longer than those of the carboxylate oxygen–Mg2+ bonds, reflecting the reduced donor power of 
neutral amide oxygen groups for hard metal ions compared to anionic carboxylates.  Interestingly, 
the H2O–Mg2+ length is shorter than both.  In fact, a wide range of Mg2+–O bond lengths has been 
observed in aminocarboxylate complexes of magnesium, attributed to the size mismatch between 
these ligands and the Mg2+ ion, which leads to the formation of distorted chelate rings and 
correspondingly elongated bonds.[69]  Such distortions can be inferred in the structure of 
Mg(AmGly2)NO3 from the marked deviation of the sum of the internal angles of each of the 
chelate rings from 540°.[70] 
 
Figure 4. Molecular structure in the crystal of the Mg(AmGly2) complex (Mg2+ shown in 
turquoise). Thermal ellipsoids are shown at the 50% probability level. For clarity, The Na+ ions 
coordinated to O2, O3, O4, O5, O11 and O12 and their associated water molecules, and only the 
heteroatoms are labelled. 
	  
Table 4. Selected bond lengths (Å) and angles (°) for Mg(AmGly2)	  
Bond distances Bond angles 
Bond Distance (Å) Atoms Angle (o) 
Mg1—N2 2.421 (3) N2—Mg1—N2 73.86 (11) 
Mg1—O3 2.2338 (19) O5—Mg1—O3 100.66 (8) 
Mg1—O5 2.087 (2) O5—Mg1—N2 73.39 (8) 
Mg1—O6 2.047 (3) O6—Mg1—O3 81.26 (6) 
 
 
Although omitted from Figure 4 for clarity, oxygen atoms O2, O3, O4 and O5 also coordinate to 
hydrated Na+ ions, a high concentration of which were available on account of the NaOH added to 
set the pH.  The Na+ ions attached to O3 and O5 also coordinate to the nitrate ion that is disordered 
across two sites.  These Na+–O interactions are the basis of an extended, wave-like polymeric 
structure, with each alternating Mg(AmGly2) unit facing in opposite directions along the b-axis.  In 
turn, these chains are linked by strong hydrogen bonds between the amide oxygen O2 on the 
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AmGly2 ligand and the hydrogen on water molecules (O8) that are coordinated to Na+ ions (Figure 
5).  
 
	   	  
	  
Figure 5.  (a) Lateral and (b) end-on views of the polymeric structure of the Mg(AmGly2)NO3 
complex.  The hydrated Na+ ions (purple) linking individual Mg(AmGly2) units, as well as the 
coordinated Mg2+ ions (turquoise), are shown as spheres for clarity. 
 
2.4  Bacterial growth inhibition studies 
 
An optical-density based method was used to assess the growth of a selection of Gram negative and 
Gram positive bacteria in small-scale liquid culture (96-well plates), in the presence of varying 
concentrations of the chelating ligands.  Studies were conducted in media of varying richness and 
salt concentration: Iso-sensitest (3 g / L NaCl) in the first instance, and in LB (Lysogeny Broth; 5 
g / L NaCl) and low-salt LB (0.5 g / L NaCl) in certain cases.  Iso-sensitest was chosen as the 
default media due to its being favoured by other workers for growth inhibition testing, including 
MIC determination,[20] along with having a more well-defined composition. 
 
Bacteria grown to an optical density of 0.07 at λ = 650 nm were diluted 10-fold in fresh medium, 
equivalent to a 0.5 MacFarland standard,[20] and incubated with varying concentrations of AmGly2 
or AmPy2 solutions; the latter were prepared in the same broth from a concentrated, aqueous, stock 
solution of either ligand.  EDTA was tested in parallel to facilitate comparisons.  To ensure the 
accuracy of stock ligand concentrations, we employed quantitative 1H NMR spectroscopy with the 
ROBUST5 pulse sequence for solvent suppression,[21] in the presence of an internal standard (t-
butanol), to determine the precise concentrations of the EDTA, AmGly2 and AmPy2 stock 
solutions.  Such an approach is preferable to relying on inferred stock concentrations from the mass 
of ligand dissolved in a given volume of water, owing to the hygroscopicity of the ligands. 
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In order to evaluate the spectrum of activity of AmGly2, AmPy2 and EDTA, we selected four 
microorganisms for study – three Gram negatives (Escherichia coli, Pseudomonas aeruginosa and 
Klebsiella pneumoniae) and one Gram positive (Staphylococcus aureus).  The K12 laboratory strain 
of E. coli was chosen as it lacks O-antigens that alter outer membrane architecture, and also because 
pathogenic variants of E. coli are important causative agents of gastrointestinal and urinary tract 
infections.[22]  P. aeruginosa is a common cause of nosocomial infections, especially in burn 
victims and cystic fibrosis sufferers;[23,24] it also differs from E. coli in the composition of its 
lipopolysaccharide (LPS) membrane.[25]  K. pneumoniae is of interest because of its pathogenicity 
and antibiotic resistance;[26] furthermore, it has the capacity to produce a capsule that may serve to 
protect it from external stressors and is critically important in subverting the host immune 
response.[27]  S. aureus was included as a Gram-positive species with a different envelope structure 
and because of its capacity for pathogenicity, including highly drug-resistant forms.[28–30]  Growth 
inhibition characteristics of EDTA, AmGly2 and AmPy2 on these four bacterial species are 
presented in Figure 6. 
 
	  
Figure 6. Effect of EDTA, AmGly2 and AmPy2 on the growth of (A) E. coli, (B) P. aeruginosa (C) 
S. aureus and (D) K. pneumoniae, in Iso-sensitest media.  Data are the average of at least three 
replicates; error bars correspond to one standard deviation from the mean. 
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The data show that at ligand concentrations between 0.1 and 3.1 mM, AmGly2 is a more potent 
inhibitor of E. coli growth than EDTA, but appears to lose efficacy above 3.1 mM, leading to 
surprisingly unaffected E. coli growth at high [AmGly2] relative to the control.  The underlying 
causes of this biphasic response are discussed later in the text.  In contrast, against P. aeruginosa, 
AmGly2 was less inhibitory than EDTA across all of the tested concentrations.  The reversal in 
relative sensitivities of the two species to AmGly2 and to EDTA in the low-to-mid concentration 
range may be associated with the fact that P. aeruginosa possesses O-antigens that are absent in the 
E. coli strain tested and also has more negatively-charged phosphate groups clustered in the core 
oligosaccharide of its LPS layer.  In contrast E. coli has fewer phosphate groups in a more dispersed 
arrangement.[31]  It may be that these different charge configurations, and the associated divalent 
cations used to stabilise the LPS layer, are affected very differently by EDTA compared to 
AmGly2. 
 
Remarkably, AmPy2, when employed at high concentration (> 25 mM), displays greater inhibition 
than the other two chelants against all three Gram negative species.  The inhibition of K. 
pneumoniae growth at high AmPy2 concentrations is especially interesting, since neither EDTA nor 
AmGly2 significantly inhibit its growth across the tested concentrations.  The polysaccharide 
capsule secreted by Klebsiella species may provide a layer of protection from chelating ligands that 
directly target the outer membrane, similar to its capacity to resist antimicrobial peptides and 
copper.[32,33]  Given the antibiotic resistance displayed by K. pneumoniae,[34] the use of ligands like 
AmPy2 may thus offer a useful strategy to control its growth. 
	  
Growth of the Gram positive S. aureus is inhibited at lower concentrations of EDTA, AmGly2 and 
AmPy2 than those required to inhibit the Gram negatives; indeed, no growth is observed at all for 
this organism at [L] > 12.5 mM.  EDTA and AmGly2 display very similar inhibitory behaviour 
against S. aureus, although AmGly2 starts to significantly inhibit growth at a lower concentration 
than EDTA (0.4 mM versus 0.8 mM respectively).  AmPy2 on the other hand, does not 
significantly inhibit the growth of S. aureus below a concentration of 1.6 mM. 
 
Gram positive bacteria lack an outer membrane, and so the detrimental effect of EDTA, AmGly2 
and AmPy2 on S. aureus cannot be due to chelation-induced lipopolysaccharide (LPS) 
damage,[35-37] which can lead to leakage of cytoplasmic contents and cell death in the case of Gram 
negatives.[38,39]  The sensitivity of S. aureus – which possesses only a single lipid bilayer – to 
EDTA, AmGly2 and AmPy2 shows clearly that chelation-induced growth inhibition is not 
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restricted to bacteria with a Gram negative envelope architecture, in agreement with previous 
findings.[40–42] 
 
As mentioned briefly, the dose responses of P. aeruginosa, S. aureus and K. pneumoniae are typical 
in that they are monophasic: beyond a critical ligand concentration, bacterial growth remains 
consistently low.  However, the intriguing biphasic dose response of E. coli to AmGly2 is unusual 
and warranted further study.  We initially surmised that this effect could be attributed to the 
aggregation of AmGly2 into a non-functional structure at higher concentrations.  However, ES-MS 
and 1H–DOSY experiments on media containing AmGly2 that had been used to culture E. coli 
showed no evidence for such aggregation (see Supporting Information, Table S2). 
 
2.5  Growth inhibition studies of E. coli mutants 
 
We turned our attention to the outer membrane since it represents the first component of the Gram 
negative cell wall that would be contacted by chemical agents.  The availability of a range of E. coli 
mutant strains exhibiting specific deficiencies in lipopolysaccharide (LPS) biosynthesis allowed us 
to investigate the potential contribution of the outer membrane in the biphasic dose response to 
AmGly2 (Figures 7 and 8).  Insertion-deletion mutants in the hldD (previously known as rfaD), 
lpxL, lpxM, waaC and waaP genes were obtained from the Keio collection.[43]  Differences in the 
structure of the LPS layer between these mutants are highlighted through the colour-coded diagram 
in Figure 7 and summarised in the caption.  The sensitivity of these mutants to AmGly2 and EDTA 
was assessed in the same way as the wild type studies in Figure 6, discussed above. 
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Figure 7.  Structure of E. coli LPS, highlighting the lipid-A, Kdo2 and HepI regions (shown in 
green, blue and purple, respectively).  Structural features affected by deletion of the lpxM, lpxL, 
waaC or waaP genes are indicated (denoted ΔlpxM, ΔlpxL, ΔwaaC and ΔwaaP) and result in the 
highlighted portions being replaced by H atoms.  The free hydroxyl groups resulting from mutation 
of lpxM or lpxL may be acylated by other fatty acids.[44]  Deletion of the hldD (ΔhldD) gene 
precludes an inversion of configuration at the highlighted stereocentre on HepI, leading to the 
mutant structure bearing the opposite epimer to the one shown. 
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Figure 8. Effect of EDTA and AmGly2 on the growth of the E. coli (A) wild-type, (B) waaP, (C) 
hldD, (D) waaC, (E) lpxL and (F) lpxM mutants of EDTA and AmGly2 in Iso-sensitest media (see 
Fig. 7 for illustration of the sites affected in the mutants).  Data for the isogenic E. coli wild-type 
are reproduced here from Figure 5 to aid comparison with the mutant strains.  Results are the 
average of three independent experiments, all performed in technical triplicate; error bars 
correspond to one standard deviation from the mean. 
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Starting from the basal components of the LPS structure (shown in green in the structure in Figure 
7), it is apparent that the lpxL and lpxM mutants are more sensitive to EDTA and AmGly2 than the 
wild type (Figure 8E–F).  Although it has been shown that free hydroxyl groups in lipid A that arise 
due to lpxL and lpxM deletion may be acylated instead by lpxX (X = L, M or P, depending on the 
gene that remains in the mutant in question) to maintain the cell permeability barrier,[44] it has been 
noted that the E. coli lpxM mutant is more permeable to certain antibiotics than the wild-type,[45] 
and that lpxL lpxM double mutants display enhanced membrane permeability, suggesting that the 
full complement of acyltransferases are needed to maintain E. coli outer membrane integrity.[46]  
The results suggest that hydrophobic components of lipid A are an important factor in protecting E. 
coli against chelating agents.  However, a biphasic response is still evident in the susceptibility of 
these strains to AmGly2 (Figure 4E-F). 
 
Mutants with differing core oligosaccharide structures (blue units in Fig. 7) were next examined.  
The Kdo2 transferase gene waaA (kdtA) is essential for E. coli growth and so this part of the 
oligosaccharide structure cannot be studied.[43] We investigated mutations that would lead to 
changes in the LPS oligosaccharide structure distal to the Kdo2 motif.  For example, the hldD 
mutant has been shown, as with lpxM, to lead to increased membrane permeability to certain 
drugs.[47,48]  From Figure 8, it can be seen that epimerisation of HepI due to hldD mutation leads to 
only a minor increase in sensitivity to EDTA and AmGly2 at higher concentrations, [L] >12.5 mM, 
relative to the wild type.  
 
The waaP gene encodes a kinase that phosphorylates HepI,[49] and deletion of waaP increases 
susceptibility to hydrophobic drugs.[50,51]  This is most likely due to a loss of the stabilising effect 
on the LPS layer of the interaction between phosphate groups with Mg2+ and Ca2+.[52]  Surprisingly, 
the waaP mutant displays a similar inhibition profile to the wild type when exposed to EDTA, 
which suggests that phosphorylation of HepI – and the coordinative interactions in which 
phosphorylated HepI participates – are not particularly important for growth in the presence of 
EDTA.  The waaP mutant is however slightly more sensitive to AmGly2 at concentrations > 3.1 
mM (as with hldD), suggesting that the recovery of E. coli growth at high concentrations of 
AmGly2 has some dependence on the HepI component of LPS.  Yet, both waaP and hldD mutants 
retain a biphasic dose response to AmGly2 (Figure 8B and C). 
 
The importance of components distal to Kdo2 in the recovery of E. coli growth at high 
concentrations of AmGly2 was probed using a waaC mutant.[51,53–55]  The protein encoded by waaC 
is responsible for the transfer of HepI to the Kdo2 fragment of LPS.[56] HepI is in turn 
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phosphorylated by WaaP and serves as the point from which other heptoses (and ultimately the O-
antigen in most pathogenic strains) are attached, meaning that the absence of waaC, and therefore 
HepI, leads to a highly truncated LPS structure in mutant cells.[57–59]  When the waaC mutant is 
exposed to AmGly2, no biphasic growth response is observed: instead, a dose response similar to 
that of EDTA is apparent, and little or no recovery of growth occurs at higher AmGly2 
concentrations (Figure 8D). 
 
We investigated whether loss of the biphasic response to AmGly2 was due to an osmotic effect on 
membrane permeability, by stressing cells in a low ionic strength LB medium (LS-LB).  When 
waaC mutants are exposed to EDTA and AmGly2 in LS-LB media, the biphasic dose response is 
restored, although the growth recovery remains considerably less pronounced than that seen for the 
wild type in Iso-sensitest (Figure 9).  This observation suggests that the restoration of growth with 
the E. coli wild type at high AmGly2 concentrations in Iso-sensitest medium may have an osmotic 
component to the mechanism, in addition to involving HepI and structures distal to it.  Viability 
assays were used to confirm that the waaC mutant is not grossly affected by the reduced salt content 
of LS-LB in comparison to normal LB media (Supporting Information, Figure S3). 
	  
Figure 9. Comparison of the growth of the E. coli waaC mutant at increasing concentrations of 
EDTA or AmGly2 in LS-LB and Iso-sensitest media.  The data for EDTA and AmGly2 on waaC in 
Iso-sensitest from Figure 3D are reproduced here to facilitate comparisons.  Data are the average 
of three independent experiments, each performed in technical triplicate, with one standard 
deviation shown by the bars. 
In investigating the importance of the outer membrane in the biphasic dose response, the role of the 
pleiotropic phoQ-phoP system was also examined.[60]  PhoQ is a membrane protein that senses 
changes in Mg2+ concentrations and, if [Mg2+] is sufficiently low, phosphorylates the transcription 
factor PhoP, which in turn functions as a transcriptional activator of the pagP and the pbgPE 
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operons among others.  Increased expression of pagP and pbgPE operon leads to LPS modification 
via the palmitoylation of Lipid A and incorporation of 4-aminoarabinose into its structure,[60] 
changes which are thought to contribute to resistance to cationic antimicrobial agents due to a 
decrease in membrane permeability.  Mutants lacking either of these genes therefore lack the ability 
to effect a reduction in membrane permeability in response to reduced [Mg2+], a condition which 
could be brought about by chelation of Mg2+ by either EDTA or AmGly2. 
 
Data for the phoQ and phoP mutants are shown in Figure 10.  It can be seen that their growth is 
completely inhibited at [EDTA] > 12.5 mM, unlike the wild type, suggesting that these genes (or 
genes activated by them) are involved in the E. coli wild type defence mechanism against chelating 
ligands that reduce the extracellular [Mg2+].  This is not the case for AmGly2, to which the phoQ 
and phoP mutants both show a biphasic dose response similar to that observed with the wild-type 
(compare Figs 10 and 6A), with the most severe inhibition once again peaking at [AmGly2] = 
3.1 mM, followed by substantially improved growth at higher concentrations.  These observations 
suggest that exposure to AmGly2 does not lead to activation of phoQ and phoP in the wild type as a 
defence mechanism, whereas with EDTA it does.  
 
	  
Figure 10. Effect of EDTA and AmGly2 on the growth of the E. coli (A) phoQ and (B) phoP 
mutants in Iso-sensitest media.  Data are the average of three independent experiments, all 
performed in technical triplicate; error bars correspond to one standard deviation from the mean. 
 
There is a slight reduction in growth of phoQ and phoP at the highest AmGly2 concentrations, 
similar to that observed with the waaP and hldD mutants (Figure 6B and C).  Since a biphasic dose 
response to AmGly2 was observed for the E. coli wild type and all of the mutants except for waaC, 
one might postulate that AmGly2 may act as a membrane permeabiliser in a similar way to EDTA, 
but may be less able to reduce extracellular metal ion concentrations.  This may result in a greater 
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flux of metal ions across damaged cell membranes when bacteria are grown in the presence of the 
AmGly2, leading to increased growth past a critical point, before which, cell membranes are 
damaged, but selectivity in ion uptake is not lost and so growth is limited by the reduced metal ion 
flux.  The waaC mutant could exhibit monophasic behaviour in Iso-sensitest, in spite of the 
increased permeability to metal ions, due to the severity of its LPS truncation, leading to more facile 
cell lysis.   
 
2.6  Fluorescence microscopy of E. coli exposed to EDTA or AmGly2 
 
To further investigate the differing effects of EDTA and AmGly2 on E. coli, fluorescent dyes were 
employed to monitor the integrity of cells exposed to these two ligands.  Concentrations of EDTA 
and AmGly2 that resulted in 15% and 50% growth reductions were selected and wild-type E. coli 
cells analysed using the SYTOTM 9 dye that distinguishes living cells with an intact outer membrane 
from those which have lost membrane integrity resulting in entry of a second added dye, namely 
propidium iodide.  Live cells (those with an intact membrane) and dead cells (those with a disrupted 
membrane) were visualized and counted and the results are shown in Figure 11.  The observations 
can be summarised as follows: 
(i) Examination of an untreated control (i.e. no ligand added) revealed that only a very 
small fraction (1.3%) of the cells present had lost membrane integrity. 
(ii) Exposure to 1.6 mM EDTA (corresponding to a 15% reduction in growth relative to the 
untreated control) resulted in 42% dead cells present in the sample being analysed.  At 
[EDTA] = 6.25 mM (50% growth inhibition), an average of 45% of the cells present in 
the sample stained as dead – only a small increase in the fraction of dead cells given the 
drastic change in growth inhibition. 
(iii) Exposure to 0.2 mM AmGly2 (15% growth inhibition) resulted in an average of 14% of 
the cells in the culture staining as dead.  When [AmGly2] was increased to 0.4 mM, the 
proportion of “dead” cells decreased to 5%. 
 
These observations suggest that the inhibitory actions of EDTA and AmGly2 on E. coli growth 
differ in their origins.  The growth reduction observed with EDTA correlates with loss of 
membrane integrity and suggests that EDTA, at least in part, reduces bacterial growth by killing a 
proportion of the cells in a way that AmGly2 does not.  
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Figure 11. Effect of EDTA and AmGly2 on the viability of E. coli wild-type cells. The proportion of 
cells stained with SYTOTM 9 (live, green) and propidium iodide (dead, red) was determined by 
fluorescence microscopy. Data are the average of five independent experiments with >3000 cells 
counted from 25 fields of view. Error bars correspond to one standard deviation from the mean. 
Representative images of each of the fields of view in the presence or absence of EDTA or AmGly2 
are also shown. The scale bar is 50 µm in all cases. 
The data may suggest that EDTA and its metal complexes interact with the E. coli outer membrane 
to a greater extent than AmGly2 and its metal complexes.  Speciation calculations based on the 
potentiometric titration data for EDTA, AmGly2 (Table 2) and their selected metal ion complexes 
(Mn+= Ca2+, Mg2+, Fe3+, Mn2+ and Zn2+) show that, at pH 7.4, AmGly2 and Mn+-AmGly2 
complexes are more negatively charged than those of EDTA (Supplementary information, Table 
S3).  Given the high negative charge density of the E. coli LPS due to its phosphate groups (Figure 
6), we suggest that the reduced membrane permeabilisation observed when E. coli is treated with 
AmGly2 compared to EDTA may be due to the greater coulombic repulsion between the LPS and 
AmGly2 / Mn+-AmGly2.  The significant charge differences in LPS structure between E. coli and P. 
aeruginosa[31] may then go some way to explain why AmGly2 fails to show a biphasic response 
with the latter organism (Figure 6A). 
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These charge differences may mean that AmGly2 is also restricted to depleting metals from the 
medium to starve cells and reduce growth.  The biphasic response observed for E. coli could fit with 
a cellular response to tolerate metal starvation.  In contrast, EDTA may target bacterial membrane 
integrity directly in addition to removing essential metals from the growth medium.  
 
 
Concluding remarks 
 
Two symmetrical bis-amide derivatives of EDTA, AmGly2 and AmPy2, have been prepared via 
novel routes and their activities in inhibiting bacterial growth have been evaluated and compared 
with that of EDTA, which is widely used as a bacteriostatic agent.  The solid state structures of 
metal free AmGly2 and its Mg2+ complex Mg(AmGly2)NO3 have also been determined, with the 
latter adopting an extended polymeric structure not unlike previous EDTA amides studied.[72] 
 
The AmPy2 ligand – although less effective at lower concentrations against E. coli, P. aeruginosa 
and S. aureus than EDTA and AmGly2 – is the only ligand of the set that displays a significant 
inhibitory effect against K. pneumoniae, albeit requiring concentrations ≥ 25 mM. 
 
The AmGly2 ligand exhibits a more powerful inhibitory effect against E. coli at lower 
concentrations than EDTA (≤ 3.1 mM) or AmPy2, but loses its efficacy at higher concentrations.  
Studies on the effect of AmGly2 and EDTA on a number of mutant E. coli strains producing 
defective LPS structures to investigate the biphasic dose response showed that only severe 
truncations in LPS led to a conventional, monophasic dose response, as demonstrated by the action 
of AmGly2 against the waaC mutant.  
 
The biphasic dose response of E. coli to AmGly2 is thought to have an osmotic component, as 
evidenced by its partial restoration in the waaC mutant in low-salt media.  More generally, work on 
the Mg2+–dependent phoQ and phoP systems showed that they are involved in the defence 
mechanism of E. coli against EDTA but not AmGly2, as shown by the similarity of the phoQ and 
phoP mutant dose response to that of the wild-type, when exposed to AmGly2. 
 
Remarkably, studies into the metal ion affinities of AmGly2 and AmPy2 show that the metal ion 
affinities to Ca2+, Mg2+, Fe3+, Mn2+ and Zn2+ are lower than those of EDTA, even when the impact 
of the ligand ionisation state on metal ion affinities are accounted for.  This contradicts previous 
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understanding on the efficacy of chelating antimicrobials: there is no simple link between metal ion 
affinity and antimicrobial efficacy.  It is clear that interactions between the outer membrane of an 
organism as well as metal ion affinity ought to be considered when rationalising efficacy. 
 
Altogether, these data provide evidence that metal ion affinity is not the primary determinant of 
bacterial growth inhibition for this class of molecules and that EDTA bis-amides warrant further 
investigation as a new class of chelating antimicrobials, potentially offering activity against more 
resistant species.  
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